University of East Anglia

Norwich, England

Collaborator: Dr. Christopher Low, University of East Anglia

Health Categories:Cardiovascular Health

Research Summary: This project focused on the developing anti‐homocysteine formulations, and evaluating their effects on markers of cardiovascular diseases in humans.

SF Summarization: This project focused on developing formulations to reduce homocysteine (a risk factor for cardiovascular diseases) and evaluated the effects on the common markers of cardiovascular diseases.

Current Status:  Completed

Stage: Clinical Study